Position in CELC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$37,340,863
+$956,914 QoQ
Shares Held
356,919
+12.0% QoQ
Ownership
0.729%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,812,079,440 across 423 Biotechnology names. CELC ranks #45 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in CELC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,340,863 | 356,919 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $36,383,949 | 318,766 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $28,699,784 | 287,746 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $13,642,352 | 276,161 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,489,889 | 261,415 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,955,272 | 292,312 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,927,994 | 300,076 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,845,139 | 257,890 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,283,813 | 200,477 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,098,772 | 189,758 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,669,048 | 183,188 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,655,737 | 181,153 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,004,113 | 182,524 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $430,950 | 42,044 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $549,471 | 39,220 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $395,705 | 39,413 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $373,399 | 41,033 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,011,603 | 108,193 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,487,963 | 112,810 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,027,610 | 112,645 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,464,104 | 102,671 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $552,289 | 38,514 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $450,570 | 49,189 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $316,123 | 54,504 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $374,025 | 53,972 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $470,073 | 72,319 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||